Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019

VN Giri; KE Knudsen; WK Kelly; HH Cheng; KA Cooney; MS Cookson; W Dahut; S Weissman; HR Soule; DP Petrylak; AP Dicker; SH AlDubayan; AE Toland; CC Pritchard; CA Pettaway; MB Daly; JL Mohler; JK Parsons; PR Carroll; R Pilarski; A Blanco; A Woodson; A Rahm; ME Taplin; TJ Polascik; BT Helfand; C Hyatt; AK Morgans; F Feng; M Mullane; J Powers; R Concepcion; DW Lin; R Wender; JR Mark; A Costello; AL Burnett; O Sartor; WB Isaacs; J Xu; J Weitzel; GL Andriole; H Beltran; A Briganti; L Byrne; A Calvaresi; T Chandrasekar; DYT Chen; RB Den; A Dobi; ED Crawford; J Eastham; S Eggener; ML Freedman; M Garnick; PT Gomella; N Handley; MD Hurwitz; J Izes; RJ Karnes; C Lallas; L Languino; S Loeb; AM Lopez; KR Loughlin; G Lu-Yao; SB Malkowicz; M Mann; P Mille; MM Miner; T Morgan; J Moreno; L Mucci; RE Myers; SM Nielsen; B O’Neil; W Pinover; P Pinto; W Poage; GV Raj; TR Rebbeck; C Ryan; H Sandler; M Schiewer; EM D. Scott; B Szymaniak; W Tester; EJ Trabulsi; N Vapiwala; EY Yu; C Zeigler-Johnson; LG Gomella

Journal article

Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019

VN Giri, KE Knudsen, WK Kelly, HH Cheng, KA Cooney, MS Cookson, W Dahut, S Weissman, HR Soule, DP Petrylak, AP Dicker, SH AlDubayan, AE Toland, CC Pritchard, CA Pettaway, MB Daly, JL Mohler, JK Parsons, PR Carroll, R Pilarski Show all

Journal of Clinical Oncology | AMER SOC CLINICAL ONCOLOGY | Published : 2020

DOI: 10.1200/JCO.20.00046

Abstract

PURPOSE Germline testing (GT) is a central feature of prostate cancer (PCA) treatment, management, and hereditary cancer assessment. Critical needs include optimized multigene testing strategies that incorporate evolving genetic data, consistency in GT indications and management, and alternate genetic evaluation models that address the rising demand for genetic services. METHODS A multidisciplinary consensus conference that included experts, stakeholders, and national organization leaders was convened in response to current practice challenges and to develop a genetic implementation framework. Evidence review informed questions using the modified Delphi model. The final framework included cr..

View full abstract

University of Melbourne Researchers

Anthony Costello Author

Grants

Awarded by National Institutes of Health

Funding Acknowledgements

Supported by National Institutes of Health Cancer Center Support Grant 5P30CA056036-19, Foundation Medicine, Myriad, Bayer, Clovis Oncology, BioReference Laboratories, Ferring Pharmaceuticals, Philadelphia Father's Day Run, Invitae, AstraZeneca, Janssen Oncology, Roche, UroSeq, Color, OncLive, Physician Education Resource, and MDx Health.